OS Therapies Incorporated (OSTX) Stock Price

OSTXStock
$1.6537.50%52W
Market Cap$76.68M
P/E
PEG Ratio
Div yield
Beta1.34

OSTX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)21.23%
Price vs S&P 500 (4W)0.28%
VGM Score47.87

OSTX Earnings Surprise History

Q2 25-0.19est. -0.12
Q3 25-0.21est. -0.12
Q4 25-0.41est. -0.14
Q1 26-0.27est. -0.19
Q2 26-0.20est. -0.23

OSTX Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.10
4.11
4.11
4.10

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
OSTXOS Therapies Incorporated
C$1.65
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About OS Therapies Incorporated

OS Therapies is a clinical-stage biopharmaceutical company developing treatments for osteosarcoma and other solid tumors in children and young adults. The company addresses an unmet medical need in pediatric and adolescent bone cancer therapeutics.